Skip to Main Content

Paper Details

CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma.
Clin Cancer Res
17
2022
B7-H3, Brain Tumor, CD8, CD8+, CD8+ T-cell, CXCL14, Glioma, IDH, Iba1, Iba1+, Iba1+ microglia/macrophages, MAPK, MHC class I, PXA, T, T-cell, chemokine, cytotoxic CD8+ T cells, diffuse glioma, genes, glioma, isocitrate, isocitrate dehydrogenase (, isocitrate dehydrogenase (IDH)-mutant astrocytoma, lower grade astrocytoma, malignant glioma, patient, patient-derived glioma cultures, pleomorphic xanthoastrocytoma, tumor, tumor-infiltrating CD8+ T cells
Author NameAffiliation
Nalin GuptaWeill Institute for Neurosciences, University of California San Francisco
Arie PerryWeill Institute for Neurosciences, University of California San Francisco
Arie PerryUniversity of California San Francisco
Arie PerryWeill Institute for Neurosciences, University of California San Francisco
Arie PerryUniversity of California San Francisco
Annette M MolinaroWeill Institute for Neurosciences, University of California San Francisco
David A SolomonUniversity of California San Francisco
David A SolomonUniversity of California San Francisco
Joanna J PhillipsWeill Institute for Neurosciences, University of California San Francisco
Joanna J PhillipsUniversity of California San Francisco
Joanna J PhillipsWeill Institute for Neurosciences, University of California San Francisco
Joanna J PhillipsUniversity of California San Francisco
  • 1 - 12

Datasets

Release 1.2